Need help finding what you are looking for?
Contact Us
PUBLISHER: Grand View Research | PRODUCT CODE: 1941800
PUBLISHER: Grand View Research | PRODUCT CODE: 1941800
Branded Generics Market Size, Share & Trends Analysis Report By Drug Class, By Application, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033
PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Branded Generic Market Summary
The global branded generics market size was estimated at USD 276.98 billion in 2025 and is projected to reach USD 453.05 billion by 2033, growing at a CAGR of 6.5% from 2026 to 2033. The market continues to be shaped by strong demand in emerging economies, where prescription behavior favors named generics supported by physician familiarity and retail-driven distribution.
Asia Pacific remains the operational core, with manufacturers sustaining volumes through established brands in chronic therapies while selectively enhancing portfolios via fixed dose combinations and reformulations. In parallel, developed markets maintain limited but stable relevance for branded generics in segments where continuity of therapy and controlled substitution remain clinically important. For instance, in June 2024, Teva Pharmaceutical Industries Ltd. launched a generic version of Novo Nordisk's Victoza, targeting a diabetes segment that had generated approximately USD 1.6 billion in annual sales prior to market transition toward newer GLP 1 therapies. The launch illustrates how branded generic players continue to capture residual value from off patent molecules with established prescribing bases.
At the same time, the operating environment is becoming more constrained due to expanding tender based procurement, tighter pricing controls, and increasing regulatory compliance costs. These factors are gradually narrowing price differentiation between branded and unbranded generics, compelling manufacturers to focus on scale, portfolio selectivity, and complex generics to sustain profitability. Overall, the market reflects a balance between persistent demand for trusted brands and structural pressure toward commoditization.
Global Branded Generics Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global branded generics market report based on drug class, application, route of administration, distribution channel, and region:
- Drug Class Outlook (Revenue, USD Million, 2021 - 2033)
- Alkylating Agents
- Antimetabolites
- Hormones
- Anti-hypertensive
- Lipid Lowering drugs
- Anti-depressants
- Anti-psychotics
- Anti-epileptics
- Others
- Application Outlook (Revenue, USD Million, 2021 - 2033)
- Oncology
- Cardiovascular Diseases
- Neurological Diseases
- Gastrointestinal Diseases
- Dermatological diseases
- Acute and Chronic Pain
- Others
- Route of Administration Outlook (Revenue, USD Million, 2021 - 2033)
- Topical
- Oral
- Parenteral
- Others
- Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy & Others
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Product Code: GVR-4-68039-943-5
Table of Contents
Chapter 1. Methodology and Scope
- 1.1 Market Segmentation & Scope
- 1.2 Segment Definitions
- 1.2.1 Drug Class
- 1.2.2 Application
- 1.2.3 Route of Administration
- 1.3 Estimates and Forecast Timeline
- 1.4 Research Methodology
- 1.5 Information Procurement
- 1.5.1 Purchased Database
- 1.5.2 GVR's Internal Database
- 1.5.3 Secondary Sources
- 1.5.4 Primary Research
- 1.6 Information Analysis
- 1.6.1 Data Analysis Models
- 1.7 Market Formulation & Data Visualization
- 1.8 Model Details
- 1.8.1 Commodity Flow Analysis
- 1.9 List of Secondary Sources
- 1.10 Objectives
Chapter 2. Executive Summary
- 2.1 Market Snapshot
- 2.2 Segment Snapshot
- 2.3 Competitive Landscape Snapshot
Chapter 3 Branded Generics Market Variables, Trends, & Scope
- 3.1 Market Lineage Outlook
- 3.2 Market Dynamics
- 3.2.1 Market Driver Analysis
- 3.2.2 Market Restraint Analysis
- 3.3 Business Environment Analysis
- 3.3.1 Industry Analysis - Porter's Five Forces Analysis
- 3.3.1.1 Supplier Power
- 3.3.1.2 Buyer Power
- 3.3.1.3 Substitution Threat
- 3.3.1.4 Threat of New Entrants
- 3.3.1.5 Competitive Rivalry
- 3.3.2 PESTLE Analysis
- 3.3.3 Pipeline Analysis
- 3.3.4 Patent Expiry Analysis
- 3.3.5 Pricing Analysis
- 3.3.1 Industry Analysis - Porter's Five Forces Analysis
Chapter 4. Branded Generics Market: Drug Class Business Analysis
- 4.1. Drug Class Market Share, 2025 & 2033
- 4.2. Drug Class Segment Dashboard
- 4.3. Market Size & Forecasts and Trend Analysis, by Drug Class, 2021 to 2033 (USD Million)
- 4.4. Alkylating Agents
- 4.4.1 Alkylating Agents Market, 2021 - 2033 (USD Million)
- 4.5. Antimetabolites
- 4.5.1 Antimetabolites Market, 2021 - 2033 (USD Million)
- 4.6. Hormones
- 4.6.1 Hormones Market, 2021 - 2033 (USD Million)
- 4.7. Anti-hypertensive
- 4.7.1 Anti-hypertensive Market, 2021 - 2033 (USD Million)
- 4.8. Lipid Lowering drugs
- 4.8.1 Lipid Lowering drugs Market, 2021 - 2033 (USD Million)
- 4.9. Anti-depressants
- 4.9.1 Anti-depressants Market, 2021 - 2033 (USD Million)
- 4.10. Anti-psychotics
- 4.10.1 Anti-psychotics Market, 2021 - 2033 (USD Million)
- 4.11. Anti-epileptics
- 4.11.1 Anti-epileptics Market, 2021 - 2033 (USD Million)
- 4.12. Others
- 4.12.1 Others Market, 2021 - 2033 (USD Million)
Chapter 5. Branded Generics Market: Application Business Analysis
- 5.1. Application Market Share, 2025 & 2033
- 5.2. Application Segment Dashboard
- 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million)
- 5.4. Oncology
- 5.4.1 Oncology Market, 2021 - 2033 (USD Million)
- 5.5. Cardiovascular Diseases
- 5.5.1 Cardiovascular Diseases Market, 2021 - 2033 (USD Million)
- 5.6. Neurological Diseases
- 5.6.1 Neurological Diseases Market, 2021 - 2033 (USD Million)
- 5.7. Gastrointestinal Diseases
- 5.7.1 Gastrointestinal Diseases Market, 2021 - 2033 (USD Million)
- 5.8. Dermatological diseases
- 5.8.1 Dermatological diseases Market, 2021 - 2033 (USD Million)
- 5.9. Acute and Chronic Pain
- 5.9.1 Acute and Chronic Pain Market, 2021 - 2033 (USD Million)
- 5.10. Others
- 5.10.1 Others Market, 2021 - 2033 (USD Million)
Chapter 6. Branded Generics Market: Route of Administration Business Analysis
- 6.1. Route of Administration Market Share, 2025 & 2033
- 6.2. Route of Administration Segment Dashboard
- 6.3. Market Size & Forecasts and Trend Analysis, by Route of Administration, 2021 to 2033 (USD Million)
- 6.4. Oral
- 6.4.1 Oral Market, 2021 - 2033 (USD Million)
- 6.5. Topical
- 6.5.1 Topical Market, 2021 - 2033 (USD Million)
- 6.4. Parenteral
- 6.4.1 Parenteral Market, 2021 - 2033 (USD Million)
- 6.5. Others
- 6.5.1 Others Market, 2021 - 2033 (USD Million)
Chapter 7. Branded Generics Market: Distribution Channel Business Analysis
- 7.1. Distribution Channel Market Share, 2025 & 2033
- 7.2. Distribution Channel Segment Dashboard
- 7.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
- 7.4. Hospital Pharmacy
- 7.4.1 Hospital Pharmacy Market, 2021 - 2033 (USD Million)
- 7.5. Retail Pharmacy
- 7.5.1 Retail Pharmacy Market, 2021 - 2033 (USD Million)
- 7.6. Online Pharmacy & Others
- 7.6.1 Online Pharmacy & Others Market, 2021 - 2033 (USD Million)
Chapter 8. Branded Generics Market: Regional Estimates & Trend Analysis
- 8.1 Regional Market Share Analysis, 2025 & 2033
- 8.2 Regional Market Dashboard
- 8.3 Market Size & Forecasts Trend Analysis, 2021 to 2033:
- 8.4 North America
- 8.4.1 North America Branded Generics Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
- 8.4.2 U.S.
- 8.4.2.1 Key Country Dynamics
- 8.4.2.2 Regulatory Framework
- 8.4.2.3 Pricing Analysis
- 8.4.2.4 U.S. Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.4.3 Canada
- 8.4.3.1 Key Country Dynamics
- 8.4.3.2 Regulatory Framework
- 8.4.3.3 Pricing Analysis
- 8.4.3.4 Canada Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.4.4 Mexico
- 8.4.4.1 Key Country Dynamics
- 8.4.4.2 Regulatory Framework
- 8.4.4.3 Pricing Analysis
- 8.4.4.4 Mexico Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5 Europe
- 8.5.1 Europe Branded Generics Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
- 8.5.2 UK
- 8.5.2.1 Key Country Dynamics
- 8.5.2.2 Regulatory Framework
- 8.5.2.3 Pricing Analysis
- 8.5.2.4 UK Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5.3 Germany
- 8.5.3.1 Key Country Dynamics
- 8.5.3.2 Regulatory Framework
- 8.5.3.3 Pricing Analysis
- 8.5.3.4 Germany Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5.4 France
- 8.5.4.1 Key Country Dynamics
- 8.5.4.2 Regulatory Framework
- 8.5.4.3 Pricing Analysis
- 8.5.4.4 France Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5.5 Italy
- 8.5.5.1 Key Country Dynamics
- 8.5.5.2 Regulatory Framework
- 8.5.5.3 Pricing Analysis
- 8.5.5.4 Italy Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5.6 Spain
- 8.5.6.1 Key Country Dynamics
- 8.5.6.2 Regulatory Framework
- 8.5.6.3 Pricing Analysis
- 8.5.6.4 Spain Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5.7 Denmark
- 8.5.8.1 Key Country Dynamics
- 8.5.8.2 Regulatory Framework
- 8.5.8.3 Pricing Analysis
- 8.5.8.4 Denmark Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5.8 Norway
- 8.5.8.1 Key Country Dynamics
- 8.5.8.2 Regulatory Framework
- 8.5.8.3 Pricing Analysis
- 8.5.8.4 Norway Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5.9 Sweden
- 8.5.8.1 Key Country Dynamics
- 8.5.8.2 Regulatory Framework
- 8.5.8.3 Pricing Analysis
- 8.5.8.4 Sweden Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.6 Asia Pacific
- 8.6.1 Asia Pacific Branded Generics Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
- 8.6.2 Japan
- 8.6.2.1 Key Country Dynamics
- 8.6.2.2 Regulatory Framework
- 8.6.2.3 Pricing Analysis
- 8.6.2.4 Japan Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.6.3 China
- 8.6.3.1 Key Country Dynamics
- 8.6.3.2 Regulatory Framework
- 8.6.3.3 Pricing Analysis
- 8.6.3.4 China Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.6.4 India
- 8.6.4.1 Key Country Dynamics
- 8.6.4.2 Regulatory Framework
- 8.6.4.3 Pricing Analysis
- 8.6.4.4 India Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.6.5 South Korea
- 8.6.5.1 Key Country Dynamics
- 8.6.5.2 Regulatory Framework
- 8.6.5.3 Pricing Analysis
- 8.6.5.4 South Korea Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.6.6 Australia
- 8.6.6.1 Key Country Dynamics
- 8.6.6.2 Regulatory Framework
- 8.6.6.3 Pricing Analysis
- 8.6.6.4 Australia Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.6.7 Thailand
- 8.6.8.1 Key Country Dynamics
- 8.6.8.2 Regulatory Framework
- 8.6.8.3 Pricing Analysis
- 8.6.8.4 Thailand Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.7 Latin America
- 8.8.1 Latin America Branded Generics Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
- 8.8.2 Brazil
- 8.8.2.1 Key Country Dynamics
- 8.8.2.2 Regulatory Framework
- 8.8.2.3 Pricing Analysis
- 8.8.2.4 Brazil Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.8.3 Argentina
- 8.8.3.1 Key Country Dynamics
- 8.8.3.2 Regulatory Framework
- 8.8.3.3 Pricing Analysis
- 8.8.3.4 Argentina Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.8 Middle East & Africa
- 8.8.1 Middle East & Africa Branded Generics Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
- 8.8.2 South Africa
- 8.8.2.1 Key Country Dynamics
- 8.8.2.2 Regulatory Framework
- 8.8.2.3 Pricing Analysis
- 8.8.2.4 South Africa Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.8.3 Saudi Arabia
- 8.8.3.1 Key Country Dynamics
- 8.8.3.2 Regulatory Framework
- 8.8.3.3 Pricing Analysis
- 8.8.3.4 Saudi Arabia Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.8.4 UAE
- 8.8.4.1 Key Country Dynamics
- 8.8.4.2 Regulatory Framework
- 8.8.4.3 Pricing Analysis
- 8.8.4.4 UAE Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.8.5 Kuwait
- 8.8.5.1 Key Country Dynamics
- 8.8.5.2 Regulatory Framework
- 8.8.5.3 Pricing Analysis
- 8.8.5.4 Kuwait Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 9. Competitive Landscape
- 9.1. Participant Overview
- 9.2. Company Market Position Analysis
- 9.3. Company Categorization
- 9.4. Strategy Mapping
- 9.5. Company Profiles/Listing
- 9.5.1 Sun Pharmaceutical Industries Ltd.
- 9.5.1.1 Overview
- 9.5.1.2 Financial Performance
- 9.5.1.3 Product Benchmarking
- 9.5.1.4 Strategic Initiatives
- 9.5.2 Teva Pharmaceutical Industries Ltd.
- 9.5.2.1 Overview
- 9.5.2.2 Financial Performance
- 9.5.2.3 Product Benchmarking
- 9.5.2.4 Strategic Initiatives
- 9.5.3 Cipla Ltd.
- 9.5.3.1 Overview
- 9.5.3.2 Financial Performance
- 9.5.3.3 Product Benchmarking
- 9.5.3.4 Strategic Initiatives
- 9.5.4 Dr. Reddy's Laboratories Ltd.
- 9.5.4.1 Overview
- 9.5.4.2 Financial Performance
- 9.5.4.3 Product Benchmarking
- 9.5.4.4 Strategic Initiatives
- 9.5.5 Lupin Ltd.
- 9.5.5.1 Overview
- 9.5.5.2 Financial Performance
- 9.5.5.3 Product Benchmarking
- 9.5.5.4 Strategic Initiatives
- 9.5.6 Aurobindo Pharma Ltd.
- 9.5.6.1 Overview
- 9.5.6.2 Financial Performance
- 9.5.6.3 Product Benchmarking
- 9.5.6.4 Strategic Initiatives
- 9.5.7 Torrent Pharmaceuticals Ltd.
- 9.5.7.1 Overview
- 9.5.7.2 Financial Performance
- 9.5.7.3 Product Benchmarking
- 9.5.7.4 Strategic Initiatives
- 9.5.8 Viatris Inc.
- 9.5.9.1 Overview
- 9.5.9.2 Financial Performance
- 9.5.9.3 Product Benchmarking
- 9.5.9.4 Strategic Initiatives
- 9.5.9 Sanofi
- 9.5.7.1 Overview
- 9.5.7.2 Financial Performance
- 9.5.7.3 Product Benchmarking
- 9.5.7.4 Strategic Initiatives
- 9.5.10 Abbott
- 9.5.8.1 Overview
- 9.5.8.2 Financial Performance
- 9.5.8.3 Product Benchmarking
- 9.5.8.4 Strategic Initiatives
- 9.5.1 Sun Pharmaceutical Industries Ltd.
Product Code: GVR-4-68039-943-5
List of Tables
- Table 1 Global Branded Generics Market, By Region, 2021 - 2033 (USD Billion)
- Table 2 Global Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
- Table 3 Global Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
- Table 4 Global Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
- Table 5 Global Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
- Table 6 North America Branded Generics Market, By Country, 2021 - 2033 (USD Billion)
- Table 7 North America Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
- Table 8 North America Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
- Table 9 North America Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
- Table 10 North America Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
- Table 11 U.S. Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
- Table 12 U.S. Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
- Table 13 U.S. Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
- Table 14 U.S. Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
- Table 15 Canada Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
- Table 16 Canada Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
- Table 17 Canada Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
- Table 18 Canada Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
- Table 19 Europe Branded Generics Market, By Country, 2021 - 2033 (USD Billion)
- Table 20 Europe Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
- Table 21 Europe Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
- Table 22 Europe Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
- Table 23 Europe Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
- Table 24 UK Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
- Table 25 UK Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
- Table 26 UK Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
- Table 27 UK Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
- Table 28 Germany Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
- Table 29 Germany Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
- Table 30 Germany Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
- Table 31 Germany Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
- Table 32 France Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
- Table 33 France Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
- Table 34 France Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
- Table 35 France Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
- Table 36 Italy Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
- Table 37 Italy Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
- Table 38 Italy Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
- Table 39 Italy Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
- Table 40 Spain Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
- Table 41 Spain Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
- Table 42 Spain Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
- Table 43 Spain Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
- Table 44 Denmark Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
- Table 45 Denmark Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
- Table 46 Denmark Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
- Table 47 Denmark Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
- Table 48 Sweden Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
- Table 49 Sweden Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
- Table 50 Sweden Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
- Table 51 Sweden Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
- Table 52 Norway Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
- Table 53 Norway Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
- Table 54 Norway Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
- Table 55 Norway Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
- Table 56 Asia Pacific Branded Generics Market, By Country, 2021 - 2033 (USD Billion)
- Table 57 Asia Pacific Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
- Table 58 Asia Pacific Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
- Table 59 Asia Pacific Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
- Table 60 Asia Pacific Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
- Table 61 Japan Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
- Table 62 Japan Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
- Table 63 Japan Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
- Table 64 Japan Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
- Table 65 China Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
- Table 66 China Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
- Table 67 China Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
- Table 68 China Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
- Table 69 India Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
- Table 70 India Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
- Table 71 India Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
- Table 72 India Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
- Table 73 Australia Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
- Table 74 Australia Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
- Table 75 Australia Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
- Table 76 Australia Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
- Table 77 South Korea Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
- Table 78 South Korea Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
- Table 79 South Korea Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
- Table 80 South Korea Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
- Table 81 Thailand Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
- Table 82 Thailand Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
- Table 83 Thailand Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
- Table 84 Thailand Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
- Table 85 Latin America Branded Generics Market, By Country, 2021 - 2033 (USD Billion)
- Table 86 Latin America Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
- Table 87 Latin America Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
- Table 88 Latin America Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
- Table 89 Latin America Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
- Table 90 Brazil Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
- Table 91 Brazil Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
- Table 92 Brazil Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
- Table 93 Brazil Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
- Table 94 Mexico Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
- Table 95 Mexico Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
- Table 96 Mexico Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
- Table 97 Mexico Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
- Table 98 Argentina Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
- Table 99 Argentina Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
- Table 100 Argentina Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
- Table 101 Argentina Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
- Table 102 Middle East & Africa Branded Generics Market, By Country, 2021 - 2033 (USD Billion)
- Table 103 Middle East & Africa Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
- Table 104 Middle East & Africa Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
- Table 105 Middle East & Africa Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
- Table 106 Middle East & Africa Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
- Table 107 South Africa Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
- Table 108 South Africa Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
- Table 109 South Africa Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
- Table 110 South Africa Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
- Table 111 Saudi Arabia Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
- Table 112 Saudi Arabia Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
- Table 113 Saudi Arabia Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
- Table 114 Saudi Arabia Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
- Table 115 UAE Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
- Table 116 UAE Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
- Table 117 UAE Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
- Table 118 UAE Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
- Table 119 Kuwait Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
- Table 120 Kuwait Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
- Table 121 Kuwait Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
- Table 122 Kuwait Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
List of Figures
- Fig. 1 Branded generics market segmentation
- Fig. 2 Market research process
- Fig. 3 Data triangulation techniques
- Fig. 4 Primary research pattern
- Fig. 5 Market research approaches
- Fig. 6 Value - chain - based sizing & forecasting
- Fig. 7 QFD modeling for market share assessment
- Fig. 8 Market formulation & validation
- Fig. 9 Commodity Flow Analysis
- Fig. 10 Branded generics market snapshot
- Fig. 11 Penetration and growth prospect mapping
- Fig. 12 Branded generics market driver impact
- Fig. 13 ANDA approvals in 2024
- Fig. 14 Number of deaths attributed to noncommunicable diseases (in million), in 2024
- Fig. 15 Branded generics market restraint impact
- Fig. 16 Annual savings from generics in the U.S. (USD billion)
- Fig. 17 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological)
- Fig. 18 Porter's Five Forces Analysis
- Fig. 19 User Perspective Analysis
- Fig. 20 Branded generics market: Drug Class Outlook, Revenue, USD Billion, 2021 - 2033 and key takeaways
- Fig. 21 Branded generics market: Drug class movement analysis
- Fig. 22 Alkylating agents market estimates and forecast, 2021 - 2033 (USD Billion)
- Fig. 23 Antimetabolites market estimates and forecast, 2021 - 2033 (USD Billion)
- Fig. 24 Hormones market estimates and forecast, 2021 - 2033 (USD Billion)
- Fig. 25 Anti - hypertensive market estimates and forecast, 2021 - 2033 (USD Billion)
- Fig. 26 Lipid lowering drugs market estimates and forecast, 2021 - 2033 (USD Billion)
- Fig. 27 Anti - depressants market estimates and forecast, 2021 - 2033 (USD Billion)
- Fig. 28 Anti - psychotics market estimates and forecast, 2021 - 2033 (USD Billion)
- Fig. 29 Anti - epileptics generic prescription pattern in India (2020)
- Fig. 30 Anti - epileptics market estimates and forecast, 2021 - 2033 (USD Billion)
- Fig. 31 Others market estimates and forecast, 2021 - 2033 (USD Billion)
- Fig. 32 Branded generics market: Application Outlook, Revenue, USD Billion, 2021 - 2033and key takeaways
- Fig. 33 Branded generics market: Application movement analysis
- Fig. 34 Oncology market estimates and forecast, 2021 - 2033 (USD Billion)
- Fig. 35 Cardiovascular diseases market estimates and forecast, 2021 - 2033 (USD Billion)
- Fig. 36 Neurological diseases market estimates and forecast, 2021 - 2033 (USD Billion)
- Fig. 37 Acute & chronic pain market estimates and forecast, 2021 - 2033 (USD Billion)
- Fig. 38 Gastrointestinal diseases market estimates and forecast, 2021 - 2033 (USD Billion)
- Fig. 39 Dermatological diseases market estimates and forecast, 2021 - 2033 (USD Billion)
- Fig. 40 Others market estimates and forecast, 2021 - 2033 (USD Billion)
- Fig. 41 Branded generics market: Route of Administration Outlook, Revenue, USD Billion, 2021 - 2033and key takeaways
- Fig. 42 Branded generics market: Route of administration movement analysis
- Fig. 43 Topical market estimates and forecast, 2021 - 2033 (USD Billion)
- Fig. 44 Oral market estimates and forecast, 2021 - 2033 (USD Billion)
- Fig. 45 Parenteral market estimates and forecast, 2021 - 2033 (USD Billion)
- Fig. 46 Others market estimates and forecast, 2021 - 2033 (USD Billion)
- Fig. 47 Branded Generics market: Distribution Channel Outlook, Revenue, USD Billion, 2021 - 2033 and key takeaways
- Fig. 48 Branded Generics Market: Distribution Channel Movement Analysis
- Fig. 49 Hospital pharmacy market estimates and forecast, 2021 - 2033 (USD Billion)
- Fig. 50 Retail pharmacy market estimates and forecast, 2021 - 2033 (USD Billion)
- Fig. 51 Online pharmacy market estimates and forecast, 2021 - 2033 (USD Billion)
- Fig. 52 Regional marketplace: Key takeaways
- Fig. 53 Regional outlook, 2025 & 2033
- Fig. 54 North America SWOT Analysis
- Fig. 55 North America. market estimates and forecast, 2021 - 2033 (USD Billion)
- Fig. 56 U.S. key country dynamics
- Fig. 57 U.S. market estimates and forecast, 2021 - 2033 (USD Billion)
- Fig. 58 Canada key country dynamics
- Fig. 59 Canada market estimates and forecast, 2021 - 2033 (USD Billion)
- Fig. 60 Europe SWOT Analysis
- Fig. 61 Europe market estimates and forecast, 2021 - 2033 (USD Billion)
- Fig. 62 UK key country dynamics
- Fig. 63 UK market estimates and forecast, 2021 - 2033 (USD Billion)
- Fig. 64 Germany key country dynamics
- Fig. 65 Germany market estimates and forecast, 2021 - 2033 (USD Billion)
- Fig. 66 France key country dynamics
- Fig. 67 France market estimates and forecast, 2021 - 2033 (USD Billion)
- Fig. 68 Spain key country dynamics
- Fig. 69 Spain market estimates and forecast, 2021 - 2033 (USD Billion)
- Fig. 70 Italy key country dynamics
- Fig. 71 Italy market estimates and forecast, 2021 - 2033 (USD Billion)
- Fig. 72 Denmark key country dynamics
- Fig. 73 Denmark market estimates and forecast, 2021 - 2033 (USD Billion)
- Fig. 74 Sweden key country dynamics
- Fig. 75 Sweden market estimates and forecast, 2021 - 2033 (USD Billion)
- Fig. 76 Norway key country dynamics
- Fig. 77 Norway market estimates and forecast, 2021 - 2033 (USD Billion)
- Fig. 78 Asia - Pacific SWOT Analysis
- Fig. 79 Asia - Pacific market estimates and forecast, 2021 - 2033 (USD Billion)
- Fig. 80 Japan key country dynamics
- Fig. 81 Japan market estimates and forecast, 2021 - 2033 (USD Billion)
- Fig. 82 China key country dynamics
- Fig. 83 China. market estimates and forecast, 2021 - 2033 (USD Billion)
- Fig. 84 India key country dynamics
- Fig. 85 India market estimates and forecast, 2021 - 2033 (USD Billion)
- Fig. 86 Australia key country dynamics
- Fig. 87 Australia market estimates and forecast, 2021 - 2033 (USD Billion)
- Fig. 88 South Korea key country dynamics
- Fig. 89 South Korea market estimates and forecast, 2021 - 2033 (USD Billion)
- Fig. 90 Thailand key country dynamics
- Fig. 91 Thailand market estimates and forecast, 2021 - 2033 (USD Billion)
- Fig. 92 Latin America SWOT Analysis
- Fig. 93 Latin America. market estimates and forecast, 2021 - 2033 (USD Billion)
- Fig. 94 Brazil key country dynamics
- Fig. 95 Brazil market estimates and forecast, 2021 - 2033 (USD Billion)
- Fig. 96 Mexico key country dynamics
- Fig. 97 Mexico market estimates and forecast, 2021 - 2033 (USD Billion)
- Fig. 98 Argentina key country dynamics
- Fig. 99 Argentina market estimates and forecast, 2021 - 2033 (USD Billion)
- Fig. 100 Middle East & Africa SWOT Analysis
- Fig. 101 MEA market estimates and forecast, 2021 - 2033 (USD Billion)
- Fig. 102 South Africa key country dynamics
- Fig. 103 South Africa market estimates and forecast, 2021 - 2033 (USD Billion)
- Fig. 104 Saudi Arabia key country dynamics
- Fig. 105 Saudi Arabia market estimates and forecast, 2021 - 2033 (USD Billion)
- Fig. 106 UAE key country dynamics
- Fig. 107 UAE market estimates and forecast, 2021 - 2033 (USD Billion)
- Fig. 108 Kuwait key country dynamics
- Fig. 109 Kuwait market estimates and forecast, 2021 - 2033 (USD Billion)
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.